» Articles » PMID: 27014191

The Evolution of Advanced Molecular Diagnostics for the Detection and Characterization of Mycoplasma Pneumoniae

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2016 Mar 26
PMID 27014191
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Over the past decade there have been significant advancements in the methods used for detecting and characterizing Mycoplasma pneumoniae, a common cause of respiratory illness and community-acquired pneumonia worldwide. The repertoire of available molecular diagnostics has greatly expanded from nucleic acid amplification techniques (NAATs) that encompass a variety of chemistries used for detection, to more sophisticated characterizing methods such as multi-locus variable-number tandem-repeat analysis (MLVA), Multi-locus sequence typing (MLST), matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS), single nucleotide polymorphism typing, and numerous macrolide susceptibility profiling methods, among others. These many molecular-based approaches have been developed and employed to continually increase the level of discrimination and characterization in order to better understand the epidemiology and biology of M. pneumoniae. This review will summarize recent molecular techniques and procedures and lend perspective to how each has enhanced the current understanding of this organism and will emphasize how Next Generation Sequencing may serve as a resource for researchers to gain a more comprehensive understanding of the genomic complexities of this insidious pathogen.

Citing Articles

Panoramic quantitative and visualization-based bibliometric analysis of Mycoplasma pneumoniae.

Wang J, Wu M, Liu M, Tuo W, Shang Y, Tao Y Infection. 2025; .

PMID: 39934470 DOI: 10.1007/s15010-025-02482-3.


Alterations in Gut Microbiota and Serum Metabolites in Children with Pneumonia.

Wang S, Liu C, Ding R, Wang S, Ye Y, He M Infect Drug Resist. 2024; 17:5097-5110.

PMID: 39584178 PMC: 11585984. DOI: 10.2147/IDR.S490547.


A comprehensive review of infection in chronic lung diseases: recent advances in understanding asthma, COPD, and bronchiectasis.

Guo Z, Gu S, Tian Z, Du B Front Med (Lausanne). 2024; 11:1437731.

PMID: 39386750 PMC: 11461384. DOI: 10.3389/fmed.2024.1437731.


Atypical pneumonia (Review).

Georgakopoulou V, Lempesis I, Tarantinos K, Sklapani P, Trakas N, Spandidos D Exp Ther Med. 2024; 28(5):424.

PMID: 39301259 PMC: 11412103. DOI: 10.3892/etm.2024.12713.


Research status and challenges of Mycoplasma pneumoniae pneumonia in children: A bibliometric and visualization analysis from 2011 to 2023.

Liu C, Wang R, Ge S, Wang B, Li S, Yan B Medicine (Baltimore). 2024; 103(11):e37521.

PMID: 38489686 PMC: 10939570. DOI: 10.1097/MD.0000000000037521.


References
1.
Kannan T, Provenzano D, Wright J, Baseman J . Identification and characterization of human surfactant protein A binding protein of Mycoplasma pneumoniae. Infect Immun. 2005; 73(5):2828-34. PMC: 1087375. DOI: 10.1128/IAI.73.5.2828-2834.2005. View

2.
Qu J, Yu X, Liu Y, Yin Y, Gu L, Cao B . Specific multilocus variable-number tandem-repeat analysis genotypes of Mycoplasma pneumoniae are associated with diseases severity and macrolide susceptibility. PLoS One. 2013; 8(12):e82174. PMC: 3867324. DOI: 10.1371/journal.pone.0082174. View

3.
Nir-Paz R, Abutbul A, Moses A, Block C, Hidalgo-Grass C . Ongoing epidemic of Mycoplasma pneumoniae infection in Jerusalem, Israel, 2010 to 2012. Euro Surveill. 2012; 17(8). View

4.
Spuesens E, Hoogenboezem T, Sluijter M, Hartwig N, van Rossum A, Vink C . Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods. 2010; 82(3):214-22. DOI: 10.1016/j.mimet.2010.06.004. View

5.
Lucier T, Heitzman K, Liu S, Hu P . Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob Agents Chemother. 1995; 39(12):2770-3. PMC: 163027. DOI: 10.1128/AAC.39.12.2770. View